|
G4 - pma/510(k) #p050017/s002 and s003.F5 - phone number: (b)(6).Device evaluation: the device evaluation could not be completed as the device or photographic evidence of lot c2311771 of ziv5-18-125-9-60 device was not returned for evaluation.It had been indicated that the complaint device was going to be returned but to date this has not happened.If the device is returned in the future, then the file will be updated accordingly.However, a photo was shared which shows the stent delivery system to be bent/kinked.Manufacturing records: prior to distribution all devices are subjected to a visual inspection and functional inspection to ensure device integrity.A review of the manufacturing records did not reveal any discrepancies that could have contributed to this complaint issue.Instructions for use and/label: there is evidence to suggest that the customer did not follow the instructions for use.Abnormal use complaints are considered to be beyond any further reasonable means of interface-related risk control by the manufacturer.It is unknown how the device will function outside of its intended use.Trending will monitor if any future investigation is required.As per the instructions for use, ifu0043 which informs the user about indications for use "the zilver vascular stent is intended for use as an adjunct to percutaneous transluminal angioplasty (pta) in the treatment of symptomatic vascular disease of the iliac arteries up to 100mm in length with a reference vessel diameter of 5 to 9mm.Patients should be suitable candidates for pta and/or stent treatment¿.As per medical advisor using the ziv in the venous sinus is an off-label/abnormal use.Image review: an image was not returned for evaluation.Root cause analysis: a definitive root cause could be attributed to abnormal use.As per medical advisor using the ziv in the venous sinus is an off-label/abnormal use it is possible that abnormal use of device may have caused issue reported, it is unknown how the device will function outside of its intended use.Confirmation of complaint: complaint is confirmed based on customer and/or rep testimony and photo provided.Corrective action/correction: product manager notified to consider re-training at the facility.Complaints of this nature will continue to be monitored for similar events.
|
|
Supplemental report is being submitted due to the completion of the investigation on 15-jan-26.The following information has been received via email on 02dec2025.1.Is an acknowledgment letter (formal notification of the complaint being received) required? no.2.Is any account action needed (credit, no charge replacement, no action, investigation results, etc.) no.3.Details of access sheath used (name, fr size, length)? not sure.4.Details of the wire guide used (name, diameter, hydrophilic)? boston v18.5.Was a stent previously placed during previous procedures? no.6.Was the approach ipsilateral or contralateral? n/a, ispilateral, contralateral (if contralateral, was the bifurcation angle steep? n/a, yes, no) contra.Up into sinus 7.Were any other defects (other than the complaint issue) observed on the delivery system prior to return (e.G., kink)? n/a, yes, no (if yes, please specify what additional defect(s) were observed and where on the device this was observed) no.8.Was resistance encountered when advancing the wire guide to the target location? yes.9.Did the tip of the delivery system cross the target location? no.
|